← FDA Drug Approvals (Drugs@FDA)

INGENOL MEBUTATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS LABS · Approved 2018-02-06

Drug application

FDA Application #

ANDA209086

Application type

Abbreviated New Drug Application (Generic)

Brand name

INGENOL MEBUTATE

Generic name

Ingenol Mebutate

Active ingredients

INGENOL MEBUTATE

Dosage form

GEL

Route

TOPICAL

Marketing status

None (Tentative Approval)

Sponsor

ACTAVIS LABS

First approval

2018-02-06

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown